Resultados da busca - McMeekin, D Scott

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents por Moxley, Katherine M., McMeekin, D. Scott

Obter o texto integral Obter o texto integral Obter o texto integral

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P por Dizon, Don S., Blessing, John A., McMeekin, D. Scott, Sharma, Sudarshan K., DiSilvestro, Paul, Alvarez, Ronald D.

Obter o texto integral Obter o texto integral Obter o texto integral

A PHASE II TRIAL OF THALIDOMIDE IN PATIENTS WITH REFRACTORY ENDOMETRIAL CANCER AND CORRELATION WITH ANGIOGENESIS BIOMARKERS: A GYNECOLOGIC ONCOLOGY GROUP STUDY por McMeekin, D. Scott, Sill, Michael W., Benbrook, Doris, Darcy, Kathleen M., Stearns-Kurosawa, Deborah J., Eaton, Lynne, Yamada, S. Diane

Obter o texto integral Obter o texto integral Obter o texto integral

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel) in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal... por Coleman, Robert L., Brady, William E., McMeekin, D. Scott, Rose, Peter G., Soper, John T., Lentz, Samuel S., Hoffman, James S., Shahin, Mark S.

Obter o texto integral Obter o texto integral Obter o texto integral

Necessity of Radical Hysterectomy for Endometrial Cancer Patients with Cervical Invasion por Lee, Taek Sang, Kim, Jae Weon, Kim, Dae Yeon, Kim, Young Tae, Lee, Ki Heon, Kim, Byoung Gie, McMeekin, D. Scott

Obter o texto integral Obter o texto integral Obter o texto integral

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study por Monk, Bradley J., Sill, Michael W., McMeekin, D. Scott, Cohn, David E., Ramondetta, Lois M., Boardman, Cecelia H., Benda, Jo, Cella, David

Obter o texto integral Obter o texto integral Obter o texto integral

A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy with Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: a Gynecologic Oncology Group Stud... por Rose, Peter G., Sill, Michael W., McMeekin, D. Scott, Ahmed, Amina, Salani, Ritu, Yamada, S. Diane, Wolfson, Aaron, Fusco, Nancy, Fracasso, Paula M.

Obter o texto integral Obter o texto integral Obter o texto integral

A phase II evaluation of Irofulven (IND#55804, NSC#683863) as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cance... por Schilder, Russell J., Blessing, John A., Shahin, Mark S., Miller, David S, Tewari, Krishnansu Sujata, Muller, Carolyn Y., Warshal, David, McMeekin, D. Scott, Rotmensch, Jacob

Obter o texto integral Obter o texto integral

Phase II trial of Cetuximab in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study por Santin, Alessandro D., Sill, Michael W., McMeekin, D. Scott, Leitao, Mario M., Brown, Jubilee, Sutton, Gregory P., Van Le, Linda, Griffin, Patricia, Boardman, Cecelia H.

Obter o texto integral Obter o texto integral Obter o texto integral

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study por Aghajanian, Carol, Sill, Michael W., Darcy, Kathleen M., Greer, Benjamin, McMeekin, D. Scott, Rose, Peter G., Rotmensch, Jacob, Barnes, Mack N., Hanjani, Parviz, Leslie, Kimberly K.

Obter o texto integral Obter o texto integral Obter o texto integral

Ultra-early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer por Mayr, Nina A., Yuh, William T. C., Jajoura, David, Wang, Jian Z., Lo, Simon S., Montebello, Joseph F., Porter, Kyle, Zhang, Dongqing, McMeekin, D. Scott, Buatti, John M.

Obter o texto integral Obter o texto integral Obter o texto integral

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass por Moore, Richard G., McMeekin, D. Scott, Brown, Amy K., DiSilvestro, Paul, Miller, M. Craig, Allard, W. Jeffrey, Gajewski, Walter, Kurman, Robert, Bast, Robert C., Skates, Steven J.

Obter o texto integral Obter o texto integral Obter o texto integral

Etiologic Heterogeneity in Endometrial Cancer: Evidence from a Gynecologic Oncology Group Trial por Brinton, Louise A., Felix, Ashley S., McMeekin, D. Scott, Creasman, William T., Sherman, Mark E., Mutch, David, Cohn, David E., Walker, Joan L., Moore, Richard G., Downs, Levi S., Soslow, Robert A., Zaino, Richard

Obter o texto integral Obter o texto integral Obter o texto integral

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial por Felix, Ashley S., Brinton, Louise A., McMeekin, D. Scott, Creasman, William T., Mutch, David, Cohn, David E., Walker, Joan L., Moore, Richard G., Downs, Levi S., Soslow, Robert A., Zaino, Richard, Sherman, Mark E.

Obter o texto integral Obter o texto integral Obter o texto integral

A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer por Moore, Kathleen N., Gunderson, Camille, Sabbatini, Paul, McMeekin, D. Scott, Mantia-Smaldone, Gina, Burger, Robert, Morgan, Mark A., Kapoun, Ann M., Brachmann, Rainer Karl, Stagg, Robert, Farooki, Azeez, O’Cearbhaill, Roisin E

Obter o texto integral Obter o texto integral Obter o texto integral

Phase II Trial of Trastuzumab in Women with Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: a Gynecologic Oncology Group Study por Fleming, Gini F., Sill, Michael W., Darcy, Kathleen M., McMeekin, D. Scott, Thigpen, J. Tate, Adler, Lisa M., Berek, Jonathan S., Chapman, Julia A., DiSilvestro, Paul A., Horowitz, Ira R., Fiorica, James V.

Obter o texto integral Obter o texto integral Obter o texto integral

Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 Trial por Felix, Ashley S, McMeekin, D Scott, Mutch, David, Walker, Joan L, Creasman, William T, Cohn, David E, Ali, Shamshad, Moore, Richard G, Downs, Levi S, Ioffe, Olga B, Park, Kay J, Sherman, Mark E, Brinton, Louise A

Obter o texto integral Obter o texto integral Obter o texto integral

A Phase II Trial of Brivanib in Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study por Powell, Matthew A., Sill, Michael W., Goodfellow, Paul J., Benbrook, Doris M., Lankes, Heather A., Leslie, Kimberly K., Jeske, Yvette, Mannel, Robert S., Spillman, Monique A, Lee, Paula S., Hoffman, James S., McMeekin, D. Scott, Pollock, Pamela M.

Obter o texto integral Obter o texto integral Obter o texto integral

A Phase II Evaluation of Aflibercept in the Treatment of Recurrent or Persistent Endometrial Cancer: a Gynecologic Oncology Group study por Coleman, Robert L., Sill, Michael W., Lankes, Heather A., Fader, Amanda Nickles, Finkler, Neil J., Hoffman, James S., Rose, Peter G., Sutton, Gregory P., Drescher, Charles W., McMeekin, D. Scott, Hu, Wei, Deavers, Michael, Godwin, Andrew K., Alpaugh, R. Katherine, Sood, Anil K.

Obter o texto integral Obter o texto integral Obter o texto integral

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer por Randall, Marcus E., Filiaci, Virginia, McMeekin, D. Scott, von Gruenigen, Vivian, Huang, Helen, Yashar, Catheryn M., Mannel, Robert S., Kim, Jae-Weon, Salani, Ritu, DiSilvestro, Paul A., Burke, James J., Rutherford, Thomas, Spirtos, Nick M., Terada, Keith, Anderson, Penny R., Brewster, Wendy R., Small, William, Aghajanian, Carol A., Miller, David S.

Obter o texto integral Obter o texto integral Obter o texto integral